{"auto_progress_calculation":false,"computation_units":"Percentage","copyright":"","data_footnote":"","data_non_statistical":false,"data_notice_class":"","data_notice_heading":"","data_notice_text":"","data_show_map":false,"data_start_values":[{"field":"Antigen or vaccine","value":"Diphtheria"},{"field":"Antigen or vaccine","value":"Haemophilus influenzae type B (Hib)"},{"field":"Antigen or vaccine","value":"Hepatitis B"},{"field":"Antigen or vaccine","value":"Mumps"}],"embedded_feature_footer":"","embedded_feature_html":"","embedded_feature_tab_title":"","embedded_feature_title":"","embedded_feature_url":"","expected_disaggregations":["Antigen"],"graph_annotations":[],"graph_limits":[],"graph_stacked_disaggregation":"","graph_title":"global_indicators.3-b-1-title","graph_titles":[],"graph_type":"line","indicator_name":"global_indicators.3-b-1-title","indicator_number":"3.b.1","national_geographical_coverage":"Canada","page_content":"","permalink":"","precision":[],"progress_calculation_options":[],"progress_status":"not_available","reporting_status":"complete","sort":"","standalone":false,"tags":[],"\u00ef\u00bb\u00bfcomposite_breakdown_label":"","SDG_GOAL":"<p>Goal 3: Ensure healthy lives and promote well-being for all at all ages</p>","SDG_TARGET":"<p>Target 3.b: Support the research and development of vaccines and medicines for the communicable and non&#x2011;communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all</p>","SDG_INDICATOR":"<p>Indicator 3.b.1: Proportion of the target population covered by all vaccines included in their national programme</p>","STAT_CONC_DEF":"    ","DATA_COMP":"    ","REC_USE_LIM":"In the CNICs 2015, the survey reported on HPV vaccination coverage for girls aged 13-14, as the vaccine was only publicly funded for girls at that time. In the CNICs 2017, the HPV vaccine estimates represents the coverage for 14-year-olds of all genders. <br><br>Pneumococcal 3 doses* - Three doses by 2nd birthday for all provinces and territories, except Nunavut and Northwest Territories where four doses are required by the child's 2nd birthday. <br><br>Estimates for the varicella vaccine are not shown for 2013 and 2015 due to data quality concerns.","SDG_GOAL__GLOBAL":"<p>Goal 3: Ensure healthy lives and promote well-being for all at all ages</p>","SDG_TARGET__GLOBAL":"<p>Target 3.b: Support the research and development of vaccines and medicines for the communicable and non&#x2011;communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all</p>","SDG_INDICATOR__GLOBAL":"<p>Indicator 3.b.1: Proportion of the target population covered by all vaccines included in their national programme</p>","un_designated_tier":"Tier I","un_custodian_agency":"World Health Organization (WHO),  United Nations International Children's Emergency Fund (UNICEF)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"United Nations Sustainable Development Goals Metadata (PDF 4.0 MB)","source_active_1":true,"source_url_text_1":"Childhood National Immunization Coverage Survey (CNICS)","source_url_1":"https://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=5185","source_organisation_1":"Statistics Canada","source_periodicity_1":"Every 2 years","source_geographical_coverage_1":"Canada","UNIT_MEASURE":"Percentage","fr":{"SDG_GOAL":"<p>Objectif 3 : Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge.</p>","SDG_TARGET":"<p>Cible 3.b : Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en\u00a0d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux\u00a0m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la\u00a0D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments</p>","SDG_INDICATOR":"<p>Indicateur 3.b.1 : Proportion de la population cible ayant re\u00e7u tous les vaccins pr\u00e9vus par le programme national</p>","STAT_CONC_DEF":"    ","DATA_COMP":"    ","REC_USE_LIM":"Dans l'ENCVE de 2015, l'enqu\u00eate rapportait la couverture vaccinale contre le VPH pour les filles \u00e2g\u00e9es de 13 \u00e0 14 ans, puisque le vaccin \u00e9tait seulement financ\u00e9 pour les filles \u00e0 ce moment-l\u00e0. Dans l'ENCVE de 2017, les estimations pour le vaccin du VPH repr\u00e9sentent la couverture vaccinale des personnes \u00e2g\u00e9es de 14 ans de tous les genre.<br><br>Pneumocoque 3 doses* - Trois doses avant le 2e anniversaire pour toutes les provinces et territoires, sauf le Nunavut et les Territoires du Nord-Ouest o\u00f9 4 doses sont requises avant le 2e anniversaire.<br><br>Les estimations pour le vaccin contre la varicelle ne sont pas pr\u00e9sent\u00e9es pour 2013 et 2015 en raison de probl\u00e8mes de qualit\u00e9 des donn\u00e9es.","SDG_GOAL__GLOBAL":"<p>Objectif 3 : Permettre \u00e0 tous de vivre en bonne sant\u00e9 et promouvoir le bien-\u00eatre de tous \u00e0 tout \u00e2ge.</p>","SDG_TARGET__GLOBAL":"<p>Cible 3.b : Appuyer la recherche et le d\u00e9veloppement de vaccins et de m\u00e9dicaments contre les maladies, transmissibles ou non, qui touchent principalement les habitants des pays en\u00a0d\u00e9veloppement, donner acc\u00e8s, \u00e0 un co\u00fbt abordable, aux\u00a0m\u00e9dicaments et vaccins essentiels, conform\u00e9ment \u00e0 la\u00a0D\u00e9claration de Doha sur l\u2019Accord sur les aspects des droits de propri\u00e9t\u00e9 intellectuelle qui touchent au commerce (ADPIC) et la sant\u00e9 publique, qui r\u00e9affirme le droit qu\u2019ont les pays en d\u00e9veloppement de tirer pleinement parti des dispositions de cet accord qui m\u00e9nagent une flexibilit\u00e9 lorsqu\u2019il s\u2019agit de prot\u00e9ger la sant\u00e9 publique et, en particulier, d\u2019assurer l\u2019acc\u00e8s universel aux m\u00e9dicaments</p>","SDG_INDICATOR__GLOBAL":"<p>Indicateur 3.b.1 : Proportion de la population cible ayant re\u00e7u tous les vaccins pr\u00e9vus par le programme national</p>","source_active_1":true,"source_url_text_1":"Enqu\u00eate nationale sur la couverture vaccinale des enfants (ENCVE)","source_url_1":"https://www23.statcan.gc.ca/imdb/p2SV_f.pl?Function=getSurvey&SDDS=5185","source_organisation_1":"Statistics Canada","source_periodicity_1":"Every 2 years","source_geographical_coverage_1":"Canada","reporting_status":"complete","un_designated_tier":"Niveau I","un_custodian_agency":"Organisation mondiale de la Sant\u00e9, Fonds des Nations Unies pour l'enfance (FISE)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"M\u00e9tadonn\u00e9es des objectifs de d\u00e9veloppement durable des Nations Unies"},"national_metadata_updated_date":"2022-01-05","national_data_updated_date":"2023-07-18","target_number":"3.b","goal_number":"3","indicator_sort_order":"03-0b-01"}